Results 251 to 260 of about 9,064,090 (287)

Verbascoside restores gastrointestinal integrity and attenuates inflammation in a rat model of 5-FU-induced mucositis. [PDF]

Med Oncol
Chukwunyere U, Sayıner S, Mercan M, Çetinel Ş, Çaliş İ, Sehirli AÖ.   +5 more
europepmc   +1 more source

Correction: Drug interactions between cephalosporins and 5-FU-based chemotherapy in the treatment of patients with gastrointestinal cancer - an exploratory cohort analysis. [PDF]

Front Pharmacol
Siegel R, Schlosser-Hupf S, Müller-Schilling M, Kharroubi SA, Gessner A, El-Najjar N.   +5 more
europepmc   +1 more source

Synthesis of 5-Fluorouracil (5-FU) coated platinum nanoparticles and apoptotic effects on U87 human glioblastoma cells. [PDF]

Cancer Cell Int
Abed A, Karimi M, Nejati M, Hamblin MR, Mirzaei SA, Sarvizadeh M, Mirzaei H.   +6 more
europepmc   +1 more source

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201. [PDF]

Oncologist
Kam AE, Zhao F, Meropol NJ, Giantonio BJ, Diasio RB, Flynn PJ, Catalano P, Hartner L, Rowland KM, Song W, Mulcahy MF, Sinicrope FA, Whitehead RP, Mayer RJ, Petrelli N, O'Dwyer PJ, Hamilton SR, Cella D, Benson AB.   +18 more
europepmc   +1 more source

PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer. [PDF]

Cell Death Dis
Jiang S, Li G, Peng S, Chen S, Pang Y, Cui H, Wang F.   +6 more
europepmc   +1 more source

Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”

Molecular Oncology, EarlyView.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres

International Journal of Pharmaceutics, 2004
The purpose of this study was to compare the combination (Paclitaxel + 5-FU microspheres) with a single drug chemotherapy (Paclitaxel and 5-FU microspheres) against metastatic breast cancer cell line (MDA-MB 435 S). The physicochemical characteristics of the microspheres (i.e.
Anshul, Gupte, Kadriye, Ciftci
openaire   +2 more sources

Effects of 5-FU

2010
5-fluorouracil (5-FU) is a chemotherapeutical agent used to treat cancers including breast and colorectal. Working as an antimetabolite to prevent cell proliferation, it primarily inhibits the enzyme thymidylate synthase blocking the thymidine formation required for DNA synthesis.
Peter M, Wigmore, Sarah, Mustafa, Maha, El-Beltagy, Laura, Lyons, Jariya, Umka, Geoff, Bennett   +5 more
openaire   +2 more sources

Conversion of a Nŏvel 5-Fluorouracil (5-FU) Derivative to 5-FU in Rats

Journal of Urology, 1983
The converting efficiency of a novel 5-FU derivative, 1, 3-didecanoyl-2-[6-[(5-fluorouracil-l-yl) carbonylamino] hexanoyl]glyceride (DFUG), to 5-FU was investigated in rat plasma. The degradation half-life of DFUG was 4.04 min when DFUG was incubated in rat plasma at 37 degrees C, though DFUG was considerably stable in buffers having different pH ...
K, Takada, H, Yoshikawa, S, Muranishi
openaire   +2 more sources